A vaccine against the new coronavirus, which is being developed by the University of Oxford, in the United Kingdom, has started human trials in Brazil, the country with the second-highest number of cases and deaths from the coronavirus pandemic. The tests began in São Paulo and Rio de Janeiro.
Moderna Pharmaceutical, the first US laboratory to test its vaccine prototype in humans, is pointing to positive results in creating an immune response to SARS-CoV-2, the pharmaceutical company announced Monday. The first tests on humans took place in March, with eight “guinea pigs,” each receiving two doses of the vaccine.
The 2019-nCoV or 2019 novel coronavirus, also known as the Wuhan coronavirus, is highly contagious in nature and causes severe respiratory infections. This virus was first identified by healthcare authorities in Wuhan, China in 2019, due to the ongoing 2019–2020 coronavirus outbreak in the city.